Hepion Pharmaceuticals HEPA
OTC HEPA
$0.10 -0.04 (-28.57%)
At close: Nov 13, 2026 · 4:00 PM EST

Hepion Pharmaceuticals (HEPA) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Hepion Pharmaceuticals' Return on Capital Employed [ROCE] came in at -172.59% for Q2 2026, up 7.66 percentage points from -180.25% a year earlier but down 1.53 percentage points from the prior quarter.

Analysis

Hepion Pharmaceuticals (HEPA) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Hepion Pharmaceuticals' Return on Capital Employed [ROCE] was -203.86%, up 84.46 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -136.63 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -288.32% in FY2024 (-145.32 pp), -143.00% in FY2023 (-81.54 pp), -61.46% in FY2022 (-16.68 pp) and -44.78% in FY2021 (+22.45 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -1330.11% (Q3 2024) to -24.27% (Q3 2021).
  • Year-over-year, Return on Capital Employed [ROCE] increased in four of the last six quarters, with an average year-over-year change of +58.81 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2025 (a gain of 1204.13 percentage points), and the weakest in Q3 2024 (a drop of 1133.76 percentage points).
  • Business Quant data shows HEPA's Return on Capital Employed [ROCE] at -171.07% (Q1 2026), -134.07% (Q4 2025) and -125.98% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 8.51%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 7.18%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 6.23%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 18.68%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 13.86%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 13.22%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 9.99%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 11.59%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 4.76%
10 Hepion Pharmaceuticals 1.62 Mn -6.76 Mn - -172.59%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -172.59%
Mar 31, 2026 -171.07%
Dec 31, 2025 -134.07%
Sep 30, 2025 -125.98%
Jun 30, 2025 -180.25%
Mar 31, 2025 -509.69%
Sep 30, 2024 -1,330.11%
Jun 30, 2024 -346.76%
Mar 31, 2024 -279.38%
Dec 31, 2023 -297.98%
Sep 30, 2023 -196.35%
Jun 30, 2023 -129.12%
Mar 31, 2023 -114.14%
Dec 31, 2022 -79.69%
Sep 30, 2022 -64.67%
Jun 30, 2022 -58.65%
Mar 31, 2022 -33.84%
Dec 31, 2021 -30.60%
Sep 30, 2021 -24.27%
Jun 30, 2021 -20.99%
API Access

Hepion Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=HEPA&period=max&api_key=YOUR_API_KEY